Ignite Creation Date:
2025-12-25 @ 3:44 AM
Ignite Modification Date:
2025-12-31 @ 3:39 PM
Study NCT ID:
NCT01850602
Status:
COMPLETED
Last Update Posted:
2018-10-09
First Post:
2013-05-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase III Study of PA21 in Hemodialysis Patients With Hyperphosphatemia
Sponsor:
Kissei Pharmaceutical Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-04-23
Start Date Type:
ACTUAL
Primary Completion Date:
2013-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-12-10
Completion Date Type:
ACTUAL
First Submit Date:
2013-05-07
First Submit QC Date:
None
Study First Post Date:
2013-05-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-03-02
Results First Submit QC Date:
None
Results First Post Date:
2018-10-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-03-02
Last Update Post Date:
2018-10-09
Last Update Post Date Type:
ACTUAL